Enlivex Therapeutics Ltd. (ENLV)
NASDAQ·Healthcare·Biotechnology
$1.01
+2.99%
Mkt Cap $28.19M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+1385.1%
Consensus $15.00 vs current $1.01
NASDAQ·Healthcare·Biotechnology
$1.01
+2.99%
Mkt Cap $28.19M
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+1385.1%
Consensus $15.00 vs current $1.01